| RS2048708701 |
ARX
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2048711878 |
ARX
|
Health Risk |
Pathogenic |
— |
| RS2048712192 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked |
| RS2048712606 |
ARX
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked |
| RS2048714302 |
PHKA2
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2048717087 |
PDE6D
|
Health Risk |
Likely pathogenic |
Joubert syndrome 22, Joubert syndrome 22 |
| RS2048744617 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2048769063 |
HDAC8
|
Health Risk |
Likely pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS2048816852 |
TCF4
|
Health Risk |
Pathogenic/Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2048818361 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS2048831313 |
ARHGEF9
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS2048833496 |
ARHGEF9
|
Health Risk |
Likely pathogenic |
— |
| RS2048834387 |
TANC2
|
Health Risk |
Likely pathogenic |
Developmental delay, Epilepsy |
| RS2048893092 |
RAD51C
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group O, Fanconi anemia complementation group O |
| RS2048894318 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2048929422 |
TANC2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2048962401 |
MYT1L
|
Health Risk |
Pathogenic |
— |
| RS2048967703 |
MYT1L
|
Health Risk |
Pathogenic |
Neurodevelopmental abnormality, Neurodevelopmental abnormality |
| RS2048968935 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS2048988947 |
TANC2
|
Health Risk |
Pathogenic/Likely pathogenic |
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY WITH SEIZURES, Neurodevelopmental disorder |
| RS2048990416 |
TANC2
|
Health Risk |
Pathogenic/Likely pathogenic |
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISTIC FEATURES AND LANGUAGE DELAY WITHOUT SEIZURES, Developmental delay |
| RS2048999762 |
TANC2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2049017627 |
TANC2
|
Health Risk |
Likely pathogenic |
Developmental delay, Developmental delay |
| RS2049019457 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS2049020585 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS2049022161 |
AMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2049025668 |
AMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 2 |
| RS2049026547 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2049038862 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2049050015 |
AMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS2049051428 |
AMT
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS2049052530 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2049052992 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2049058298 |
AMT
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2049058963 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS2049059647 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2049060332 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2049060862 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2049072767 |
NAGS
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperammonemia, type III |
| RS2049079486 |
NAGS
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperammonemia, type III |
| RS2049080644 |
NAGS
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperammonemia, type III |
| RS2049082368 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS2049086224 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2049089565 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS2049097502 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS2049097522 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2049106256 |
NAGS
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperammonemia, type III |
| RS2049106504 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS2049106859 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS2049119534 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy 1, Glycine encephalopathy 1 |
| RS2049123051 |
AMT
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS2049124862 |
AMT
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS2049262622 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2049301523 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS2049307995 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2049339111 |
COG4
|
Health Risk |
Likely pathogenic |
— |
| RS2049398530 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2049409571 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS2049473367 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS2049489016 |
KCNMA1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Liang-Wang syndrome |
| RS2049504624 |
MADD
|
Health Risk |
Pathogenic |
Deeah syndrome, Deeah syndrome |
| RS2049521857 |
ANO4
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2049522225 |
ANO4
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2049528619 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2049531217 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2049552830 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2049559202 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2049559215 |
PPARG
|
Health Risk |
Likely pathogenic |
Obesity, Obesity |
| RS2049559372 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2049563238 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2049564336 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2049566471 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS2049568799 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS2049572412 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2049594204 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS2049594311 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS2049604095 |
SOD1
|
Health Risk |
Likely pathogenic |
— |
| RS2049618449 |
SOD1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS2049629009 |
ACE
|
Health Risk |
Likely pathogenic |
— |
| RS2049640804 |
MADD
|
Health Risk |
Pathogenic |
Deeah syndrome, Deeah syndrome |
| RS2049677875 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2049710031 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2049726544 |
COG4
|
Health Risk |
Pathogenic |
COG4-congenital disorder of glycosylation, COG4-congenital disorder of glycosylation |
| RS2049733161 |
MYL11
|
Health Risk |
Pathogenic/Likely pathogenic |
Distal arthrogryposis, Arthrogryposis |
| RS2049738010 |
ACE
|
Health Risk |
Pathogenic |
Renal tubular dysgenesis, Renal tubular dysgenesis |
| RS2049768364 |
MYL11
|
Health Risk |
Pathogenic/Likely pathogenic |
Distal arthrogryposis, Arthrogryposis |
| RS2049829612 |
GRK1
|
Health Risk |
Likely pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS2049829935 |
GRK1
|
Health Risk |
Likely pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS2049830881 |
GRK1
|
Health Risk |
Likely pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS2049858551 |
GRK1
|
Health Risk |
Likely pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS2049935254 |
GRK1
|
Health Risk |
Likely pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS2049944547 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2049960403 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2049985232 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2049992612 |
GRK1
|
Health Risk |
Likely pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS2049994399 |
GRK1
|
Health Risk |
Likely pathogenic |
Oguchi disease-2, Oguchi disease-2 |
| RS2050008898 |
EPG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS2050024015 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2050024892 |
TTN
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 9, Hypertrophic cardiomyopathy 9 |
| RS2050027504 |
EPG5
|
Health Risk |
Pathogenic/Likely pathogenic |
Vici syndrome, Vici syndrome |